Clinical study of tranexamic acid drug-infiltrated threads for the treatment of melasma

Phase 1

• Conditions: melasma

• Registration Number: ITMCTR2022000039
• Lead Sponsor: Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

(1) Age 18 to 60 years old, female;
(2) Those who have not received acupuncture point burial thread treatment before;
(3) Meet the diagnostic criteria for melasma;
(4) The clinical stage is a stable stage;
(5) Each patient understands the purpose and method of this study before the trial, and voluntarily participates in it, and signs the informed consent of the trial Book.

Exclusion Criteria

(1) Pregnant or lactating women;
(2) Patients who are allergic to the use of drugs in this study;
(3) Patients with inflammatory or infectious skin diseases at the treatment site;
(4) Patients with severe endocrine, gynecological, cardiovascular and cerebrovascular diseases, abnormal coagulation function, abnormal liver and kidney function and tumors;
(5) Those who have received laser treatment, oral or topical freckle removal drugs in the past 1 month;
(6) If the sunscreen cannot be achieved as required during the treatment.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Melasma area severity index;Patient satisfaction evaluation;